Tomi Lanz

Vutrisiran Snags FDA Approval for TTR Amyloidosis Cardiomyopathy

March 21, 2025

MedPage Today) -- Gene-silencing therapy vutrisiran (Amvuttra) graduated to a broad indication in treatment of transthyretin amyloidosis cardiomyopathy, as Alnylam...

Tomi Lanz

Vutrisiran Snags FDA Approval for TTR Amyloidosis Cardiomyopathy

The White Lotus Finally Went Full Incest With Saxon and Lochlan

People Who Use Weed Daily Could Have an Elevated Risk for This Deadly Condition

VR gaming scans reveal unique brain activity in children with ADHD

Stem cell study shows lactic acid bacteria may inhibit cervical cancer development

Jolie Shower Head Review: The Best Filtered Option You Can Buy

You think red dye no. 3 is dangerous? This is 125 times worse.

The CIA believes COVID most likely originated from a lab but has low confidence in its own finding

Which style of yoga is right for me? Here’s a primer, with a caveat

As schools in LA reopen, parents worry about harmful ash from wildfires

The only person in the world with a functioning pig organ is thriving after a record 2 months

The White Lotus Finally Went Full Incest With Saxon and Lochlan

People Who Use Weed Daily Could Have an Elevated Risk for This Deadly Condition

VR gaming scans reveal unique brain activity in children with ADHD

Stem cell study shows lactic acid bacteria may inhibit cervical cancer development

Jolie Shower Head Review: The Best Filtered Option You Can Buy

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories